Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab

por Hsu, Chiun, Rimassa, Lorenza, Sun, Hui-Chuan, Vogel, Arndt, Kaseb, Ahmed O.
Publicado 2021

Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives

por Hsu, Chih-Hung, Shen, Ying-Chun, Shao, Yu-Yun, Hsu, Chiun, Cheng, Ann-Lii
Publicado 2014

Trial Designs for Integrating Novel Therapeutics into the Management of Intermediate-Stage Hepatocellular Carcinoma

por Su, Yung-Yeh, Liu, Yi-Sheng, Hsiao, Chin-Fu, Hsu, Chiun, Chen, Li-Tzong
Publicado 2022

Safety and Preliminary Efficacy of Ramucirumab in Combination with FOLFOX4 in Patients with Advanced Hepatocellular Carcinoma: A Nonrandomized, Open‐Label, Phase Ib Study

por Lin, Chia‐Chi, Yang, Tsai‐Sheng, Yen, Chia‐Jui, Cheng, Rebecca, Liu, Junjun, Hsu, Chiun
Publicado 2020

Combination of GT90001 and nivolumab in patients with advanced hepatocellular carcinoma: a multicenter, single-arm, phase 1b/2 study

por Hsu, Chiun, Chang, Yi-Fang, Yen, Chia-Jui, Xu, Yu-Wei, Dong, Min, Tong, You-Zhi
Publicado 2023

Genomic and Transcriptomic Landscape of an Oral Squamous Cell Carcinoma Mouse Model for Immunotherapy

por Lee, Yi-Mei, Hsu, Chia-Lang, Chen, Yu-Hsin, Ou, Da-Liang, Hsu, Chiun, Tan, Ching-Ting
Publicado 2023

Simultaneous visualization of the subfemtomolar expression of microRNA and microRNA target gene using HILO microscopy

por Lin, Yi-Zhen, Ou, Da-Liang, Chang, Hsin-Yuan, Lin, Wei-Yu, Hsu, Chiun, Chang, Po-Ling
Publicado 2017

Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic Adenocarcinoma

por Yang, Shih-Hung, Lee, Jen-Chieh, Chen, Bang-Bin, Kuo, Sung-Hsin, Hsu, Chiun, Bai, Li-Yuan
Publicado 2022

Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway

por Ou, Da-Liang, Lee, Bin-Shyun, Chang, Ya-Chi, Lin, Liang-In, Liou, Jun-Yang, Hsu, Chiun, Cheng, Ann-Lii
Publicado 2013

Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin

por Ou, Da-Liang, Lee, Bin-Shyun, Lin, Liang-In, Liou, Jun-Yang, Liao, Sheng-Chieh, Hsu, Chiun, Cheng, Ann-Lii
Publicado 2014

Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer

por Hsieh, Ching-Hung, Jian, Cheng-Zhe, Lin, Liang-In, Low, Guan-Sian, Ou, Ping-Yun, Hsu, Chiun, Ou, Da-Liang
Publicado 2022

Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis

por Zou, Yiyu, Tsai, Wen-Bin, Cheng, Chien-Jui, Hsu, Chiun, Chung, Young Min, Li, Pao-Chen, Lin, Sue-Hwa, Hu, Mickey CT
Publicado 2008

Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review

por Park, Joon Oh, Oh, Do-Youn, Hsu, Chiun, Chen, Jen-Shi, Chen, Li-Tzong, Orlando, Mauro, Kim, Jong Seok, Lim, Ho Yeong
Publicado 2015

Fully digital problem-based learning for undergraduate medical students during the COVID-19 period: Practical considerations

por Chao, Chia-Ter, Tsai, Chiao-Lin, Lin, Mong-Wei, Yang, Chih-Wei, Ho, Chao-Chi, Chen, Huey-Ling, Hsu, Chiun, Sheu, Bor-Ching
Publicado 2022

14-3-3ε Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma

por Liu, Tzu-An, Jan, Yee-Jee, Ko, Bor-Sheng, Liang, Shu-Man, Chen, Shyh-Chang, Wang, John, Hsu, Chiun, Wu, Yao-Ming, Liou, Jun-Yang
Publicado 2013

Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma

por Chen, Bang-Bin, Shao, Yu-Yun, Lin, Zhong-Zhe, Hsu, Chih-Hung, Cheng, Ann-Lii, Hsu, Chiun, Liang, Po-Chin, Shih, Tiffany Ting-Fang
Publicado 2021

Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials

por Chen, Bang-Bin, Lin, Zhong-Zhe, Shao, Yu-Yun, Hsu, Chiun, Hsu, Chih-Hung, Cheng, Ann-Lii, Liang, Po-Chin, Shih, Tiffany Ting-Fang
Publicado 2021

Eastern asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma

por Yeo, Winnie, Chen, Pei-Jer, Furuse, Junji, Han, Kwang-Hyub, Hsu, Chiun, Lim, Ho-Yeong, Moon, Hanlim, Qin, Shukui, Yeoh, Ee-Min, Ye, Sheng-Long
Publicado 2010

Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma

por Ou, Da-Liang, Shyue, Song-Kun, Lin, Liang-In, Feng, Zi-Rui, Liou, Jun-Yang, Fan, Hsiang-Hsuan, Lee, Bin-Shyun, Hsu, Chiun, Cheng, Ann-Lii
Publicado 2015

Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages

por Ou, Da-Liang, Chen, Chia-Wei, Hsu, Chia-Lang, Chung, Chih-Hung, Feng, Zi-Rui, Lee, Bin-Shyun, Cheng, Ann-Lii, Yang, Muh-Hwa, Hsu, Chiun
Publicado 2021